ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic criteria"

  • Abstract Number: 2136 • ACR Convergence 2025

    Confirming The Validity Of The New EULAR/ACR Classification Criteria For Pediatric Chronic Nonbacterial Osteomyelitis

    Greta Mastrangelo1, Edan Itzkovitz2, Katherine Sawicka3, Ingrid Goh4, Ari Bitnun5, Sevan Hopyan5, Paul Nathan2, Ronald laxer1 and Brian Feldman1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, 3The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 4University of Toronto The Hospital for Sick Children, Toronto, ON, Canada, 5The Hospital for Sick Children, Toronto, Canada

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is a noninfectious autoinflammatory bone disease which remains a diagnosis of exclusion, as existing diagnostic criteria are not widely accepted.…
  • Abstract Number: 0551 • ACR Convergence 2025

    Enthesitis Beyond the Surface: Ultrasonographic Unmasking of Preclinical Psoriatic Arthritis in Cutaneous Psoriasis

    Victor Cazac1 and Eugeniu Russu2, 1Norwalk Hospital, Nuvance Health, Connecticut, 2"Nicolae Testemitanu" State Medical and Pharmaceutical University; ”Timofei Moșneaga” Republican Clinical Hospital, Chisinau, Moldova

    Background/Purpose: Psoriatic arthritis (PsA) develops insidiously from psoriasis (PsO), with enthesitis representing a critical initial site of inflammation. Musculoskeletal ultrasonography (MSUS) enables the identification of…
  • Abstract Number: 1974 • ACR Convergence 2025

    Serial ferritin as a diagnostic surrogate marker in Hemophagocytic Lymphohistiocytosis (HLH), a retrospective single-center study

    Chen Chao1, Anna Lichtiger2, Xianhong Xie3, Melissa Fazzari4 and Ayesha Bibi5, 1Rheumatology Division, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, NY, 2Internal Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, NY, 3Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, 4Department of Epidemiology & Population Health, Albert Einstein College of Medicine,, Bronx, NY, 5Rheumatology Division, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Woodbridge Township, NJ

    Background/Purpose: Hemophagocytic lymphohistiocytosis (HLH) is an immune-mediated disorder characterized by cytokine dysregulation, resulting in multi-organ involvement and high mortality. (1-2) There is a time lag…
  • Abstract Number: 0837 • ACR Convergence 2025

    Risk of New Proteinuria in Next Ten Years in SLE

    Michelle Petri1, Ilayda Demirayak2, Andrea Fava3, Daniel Goldman1 and Laurence Magder4, 1Johns Hopkins University School of Medicine, Timonium, MD, 2Istanbul University, Istanbul, Turkey, 3Johns Hopkins University, Baltimore, MD, 4University of Maryland, Baltimore, Baltimore, MD

    Background/Purpose: The current 2024 ACR Lupus Nephritis guidelines recommend checking the urine protein to creatinine ratio (UPCR) every 6-12 months. Early recognition of lupus nephritis…
  • Abstract Number: 1959 • ACR Convergence 2025

    The development and validation of a Diagnostic Ultrasound Enthesitis Score (DUET) for Psoriatic Arthritis

    Lihi Eder1, Ricardo Acayaba de Toledo2, Catherine Bakewell3, Philippe Carron4, Basant Elnady5, Amir Haddad6, Arthur Kavanaugh7, Fahmeen J. Afgani8, Arnon Katz9, Minna Kohler10, josefina marin11, Nam Nguyen12, Adrien NZEUSSEU TOUKAP13, Ari Polachek14, Ernesto Rodriguez15, Marcos Rosemffet16, Abha Singh17, Maria S. Stoenoiu18, Agnes Szentpetery19, Iliara Tinazzi20, Janeth Yinh21, Mu Yang22, Richard Cook22, Gurjit Kaeley23 and Sibel Aydin24, 1University of Toronto, Toronto, ON, Canada, 2Centro Integrado de Pesquisas (CIP) do Hospital de Base de São José do Rio Preto, São José do Rio Preto, Brazil, 3Intermountain Healthcare Medical Group, Salt Lake City, 4Ghent University and VIB Center for Inflammation Research, Ghent, Belgium, 5Research Centre at Al Hada Armed Forces Hospital, Cairo, Egypt, 6Carmel Medical Center, Haifa, Israel, 7University of California, San Diego, School of Medicine, San Diego, CA, 8Women's College Hospital, Toronto, Canada, 9GRAPPA, Seattle, 10Massachusetts General Hospital, Harvard Medical School, Boston, MA, 11Hospital Universitario Rey Juan Carlos, Madrid, Spain, 12University of Toronto, Toronto, Canada, 13Cliniques Universitaires Saint-Luc, St.-Lambrechts-Woluwe, Belgium, 14Rheumatology Institute of Beilinson Hospital, Petah Tikva, Israel, 15Florida Medical Clinic, Tampa, 16Instituto de Rehabilitación Psicofísica, Capital Federal, Argentina, 17Altman Clinical and Translational Research Institute, University of California San Diego, San Diego, CA, 18Cliniques Universitaires Saint-Luc, Brussels, Belgium, 19Uppsala University Hospital, Djursholm, Sweden, 20Ospedale Sacro Cuore-Don Calabria, Verona, Italy, 21Massachusetts General Hospital, Boston, MA, 22University of Waterloo, Waterloo, Canada, 23UF COM-J, Ponte Vedra Beach, FL, 24Department of Medicine, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Background/Purpose: Enthesitis is a key lesion in psoriatic arthritis (PsA). The Diagnostic Ultrasound Enthesitis Tool (DUET) study aimed to develop and validate a novel sonographic…
  • Abstract Number: 0772 • ACR Convergence 2025

    Redefining When to Biopsy the Kidney in Patients with SLE

    Michelle Petri1, Andrea Fava2, Mohamed Atta3, Avi Rosenberg3, Sanchit Sanyal3, Peter Izmirly4, Erin Carter5, Mala Masson6, Michael Belmont7, Jennifer Barnas8, Jennifer Anolik9, Brad Rovin10 and Jill Buyon4, 1Johns Hopkins University School of Medicine, Timonium, MD, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins University School of Medicine, Baltimore, MD, 4NYU Grossman School of Medicine, New York, NY, 5New York University Grossman School of Medicine, New York, NY, 6NYU Langone Medical Center- Division of Rheumatology, New York, NY, 7NYU Langone Health, New York, NY, 8University of Rochester, Rochester, NY, 9University of Rochester Medical Center, Rochester, NY, 10The Ohio State University, Columbus, OH

    Background/Purpose: Current ACR, EULAR and KDIGO guidelines recommend kidney biopsy in SLE patients with urine protein to creatinine (UPCR) ratio of >= 0.50 g/g. However,…
  • Abstract Number: 1900 • ACR Convergence 2025

    Capturing Patient Cohorts: A Temporal Arteritis Classifier

    Megan Sullivan1, Joseph Rosen1, Christopher Grilli1, Kenneth Warrington2 and Victor E Ortega1, 1Mayo Clinic Arizona, Scottsdale, AZ, 2Mayo Clinic, ROCHESTER, MN

    Background/Purpose: Giant cell arteritis (GCA) is a granulomatous vasculitis affecting cranial and large arteries in individuals over 50 years of age. Its relative rarity poses…
  • Abstract Number: 0745 • ACR Convergence 2025

    Prevalence and Clinical Significance of Low ESR and CRP in Giant Cell Arteritis: A Population Based Study

    Eugenio de Miguel, Natalia López-Juanes, Maria-Eugenia Miranda-Carus, Carlota Ureta, Chamaida Plasencia-Rodríguez and Irene Monjo Henry, Hospital Universitario La Paz, Madrid, Spain

    Background/Purpose: Traditionally, elevated erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) had been considered a hallmark of GCA and both are included in the 2022…
  • Abstract Number: 1889 • ACR Convergence 2025

    Navigating Diagnostic Challenges: Insights into the Patient Journey and Delays in Diagnosing Dermatomyositis from a Real-world Survey in the United States and Europe

    Esther Yi1, Jason Xenakis1, Chris Blazos2, Jade Garratt-Wheeldon2, James Piercy2, Peter Anderson2 and Rohit Aggarwal3, 1Pfizer Inc., New York, United States of America, New York, 2Adelphi Real World, Bollington, United Kingdom, Bollington, United Kingdom, 3University of Pittsburgh, Rheumatology and Clinical Immunology, Pittsburgh, United States of America, Pittsburgh, PA

    Background/Purpose: Idiopathic inflammatory myopathies (IIMs) are a heterogenous group of rare autoimmune inflammatory rheumatic diseases, including dermatomyositis (DM).Methods: Data were drawn from the Adelphi Real…
  • Abstract Number: 0530 • ACR Convergence 2025

    Evaluating ChatGPT’s Performance in Diagnosing Low Back Pain: A Comparison with Clinicians and Impact of Prompted Specialties

    Annika Nack1, Xabier Michelena Vegas2, Pol Maymó-Paituvi3, Cristina Calomarde-Gómez4, david lobo5, Asier García-Alija6, Raquel Ugena-García4, Maria Aparicio1, Paola Vidal Montal7 and Diego Benavent8, 1Hospital Germans Trias i Pujol, Barcelona, Spain, 2Hospital Universitari Vall Hebron, Barcelona, Spain, 3Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain, 4Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 5Doctor Josep Trueta University Hospital, Girona, Catalonia, Spain, 6Sant Pau Hospital, Barcelona, Catalonia, Spain, 7Bellvitge University Hospital, Barcelona, Spain, 8Hospital Universitari de Bellvitge, Madrid, Spain

    Background/Purpose: Low back pain (LBP) is a multifactorial condition managed by various specialists. AI chatbots like ChatGPT may help clinicians identify probable diagnoses. Given that…
  • Abstract Number: 1710 • ACR Convergence 2025

    Defining sonographic enthesitis in psoriatic arthritis: Developing a data- and expert-driven definition for inflammatory enthesitis at the single enthesis level

    Andre Lucas Ribeiro1, Sibel Aydin2, Gurjit Kaeley3, Fahmeen J. Afgani4, Catherine Bakewell5, Marcos Rosemffet6, Minna Kohler7, Amir Haddad8, Maria S. Stoenoiu9, Ari Polachek10, josefina marin11, Arnon Katz12, Sahil Koppikar13 and Lihi Eder14, 1Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil, 2Department of Medicine, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, Canada, 3UF COM-J, Ponte Vedra Beach, FL, 4Women's College Hospital, Toronto, Canada, 5Intermountain Healthcare, Salt Lake City, UT, 6Instituto de Rehabilitación Psicofísica, Capital Federal, Argentina, 7Massachusetts General Hospital, Harvard Medical School, Boston, MA, 8Carmel Medical Centre, Haifa, Israel, 9Cliniques Universitaires Saint-Luc, Brussels, Belgium, 10Rheumatology Institute of Beilinson Hospital, Petah Tikva, Israel, 11Hospital Universitario Rey Juan Carlos, Madrid, Spain, 12GRAPPA, Seattle, 13Women's College Hospital & University of Toronto, Markham, ON, Canada, 14University of Toronto, Toronto, ON, Canada

    Background/Purpose: Enthesitis affects 30–40% of PsA patients but remains difficult to diagnose due to overlap with non-specific entheseal pain. While OMERACT has standardized ultrasound (US)…
  • Abstract Number: 0507 • ACR Convergence 2025

    Diagnostic performance of the lacrimal and salivary gland ultrasound in patients with primary Sjogren’s disease of recent onset versus sicca controls.

    Rosa Elena Cervantes1, Carina Soto-Fajardo2, Fabian Carranza3, Gabriela Hernandez-Molina4, Narlly Ruíz Quintero5, Daniela Rojas Abarca6, Ana Mora7, Ada Rocío Morales Meza6, Carlos Montiel Castañeda8, Angela Maldonado Luna9, Fabiola Sánchez Zamudio6 and Carlos Pineda2, 1National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra"", Mexico City, Distrito Federal, Mexico, 2National Rehabilitation Institute " Luis Guillermo Ibarra Ibarra ", Mexico City, Mexico, 3National Rehabilitation Institute " Luis Guillermo Ibarra Ibarra ", Ciudad de México, Mexico, 4Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Federal District, Mexico, 5Instituto Nacional de Ciencias Medicas y Nutricion, México, city, Distrito Federal, Mexico, 6National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Mexico, City, Distrito Federal, Mexico, 7National Rehabilitation Institute " Luis Guillermo Ibarra Ibarra ", Mexico, Mexico, 8National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", México, city, Distrito Federal, Mexico, 9Instituto Nacional de Ciencias Medicas y Nutricion, Mexico, City, Estado de México, Mexico

    Background/Purpose: Sjögren's disease (SjD) is a chronic systemic autoimmune disease primarily affecting the exocrine glands. There is an increasing use of salivary gland ultrasound in…
  • Abstract Number: 1672 • ACR Convergence 2025

    Classification criteria, disease phenotypes and long-term outcomes of childhood Sjögren’s Disease into adulthood

    Coziana Ciurtin1, Ruby Gotch2, Hannah Peckham1, Robert Wilson2, Muthana AlObaidi3 and Elizabeth C Jury1, 1University College London, London, United Kingdom, 2University College London Hospital NHS Trust, London, United Kingdom, 3Great Ormond Street Hospital, London, United Kingdom

    Background/Purpose: Childhood Sjögren Disease (cSjD) is a rare clinical phenotype lacking research on long-term outcomes and impact on the quality of life of young people…
  • Abstract Number: 0469 • ACR Convergence 2025

    Evaluating Large Language Models for Automated Joint Involvement Analysis in Rheumatoid Arthritis

    Xingyi Liu1, Sunghwan Sohn1 and Cynthia Crowson2, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Stewartvillle, MN

    Background/Purpose: In rheumatoid arthritis (RA), delaying initiation of treatment for 12 weeks or longer may lead to permanent joint damage and make remission harder to…
  • Abstract Number: 1477 • ACR Convergence 2025

    Can Large Language Models Support Clinical Decision-Making in Atypical SLE? A Comparative Analysis

    Beste Acar1, Berkay Aktas1, Oguzhan Omer Kizilkaya1, Zekayi Kutlubay2 and serdal Ugurlu3, 1Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey, 2Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Dermatology, Istanbul, Turkey, Istanbul, Istanbul, Turkey, 3Istanbul University-Cerrahpasa, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey

    Background/Purpose: This study evaluates the contributions of large language models (LLMs) in clinical decision-making for atypical presentations of systemic lupus erythematosus (SLE). It focuses on…
  • 1
  • 2
  • 3
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology